Close Menu

NEW YORK – The US Centers for Disease Control and Prevention said Friday that it has validated a new protocol for its assay to detect SARS-CoV-2, the virus that causes the novel coronavirus disease COVID-19. Local labs that have the test kits already can use them with a modified protocol, and the agency will also ship new kits.

With the new modifications, state and local public health labs will be able to test possible cases more locally. Meanwhile, the surveillance testing that has been previously described will likely be up and running at six initial sites by next week.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A German shepherd called Nala has had her genome sequenced.

A coronavirus serology test garners Emergency Use Authorization from the US Food and Drug Administration, but the Los Angeles Times asks: how will tests like that be used?

Certain gene variants in conjunction with a healthy lifestyle may keep brains young, according to New Scientist.

In Science this week: increased CD8 T cell density and increased IFN-gamma response may indicate metastatic prostate cancer patients who will respond to immune checkpoint blockade therapy.

Sponsored by

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.